Ballast Inc’s AbbVie ABBV Stock Holding History

Ballast Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$829K	Sell	3,294 -30	-0.9%	-$6.45K	0.16%	75
2026 Q1	$723K	Hold	3,324	–	–	0.17%	71
2025 Q4	$760K	Buy	3,324 +192	+6%	+$43.7K	0.18%	72
2025 Q3	$725K	Hold	3,132	–	–	0.18%	72
2025 Q2	$581K	Hold	3,132	–	–	0.15%	76
2025 Q1	$656K	Buy	3,132 +22	+0.7%	+$4.28K	0.19%	73
2024 Q4	$553K	Sell	3,110 -2	-0.1%	-$368	0.16%	79
2024 Q3	$615K	Sell	3,112 -46	-1%	-$8.59K	0.17%	76
2024 Q2	$542K	Buy	3,158 +48	+2%	+$7.95K	0.17%	78
2024 Q1	$566K	Hold	3,110	–	–	0.18%	76
2023 Q4	$482K	Buy	3,110 +1,356	+77%	+$198K	0.17%	76
2023 Q3	$261K	Hold	1,754	–	–	0.1%	98
2023 Q2	$236K	Hold	1,754	–	–	0.09%	108
2023 Q1	$280K	Hold	1,754	–	–	0.11%	92
2022 Q4	$283K	Hold	1,754	–	–	0.12%	93
2022 Q3	$235K	Hold	1,754	–	–	0.11%	100
2022 Q2	$268K	Sell	1,754 -22	-1%	-$3.36K	0.13%	87
2022 Q1	$287K	Buy	1,776 +144	+9%	+$20.9K	0.11%	94
2021 Q4	$220K	Buy	+1,632	New	+$193K	0.09%	105

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ballast Inc's ABBV Position: Q2 2026 in Review

Ballast Inc reduced its AbbVie (ABBV) stake by 0.9% in Q2 2026, selling an estimated $6.45K and leaving 3,294 shares worth $829K. The position accounts for 0.16% of the portfolio, ranked #75.

Ballast Inc first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ballast Inc held 3,294 shares of AbbVie worth $829K as of Q2 2026.
Ballast Inc sold 30 AbbVie shares in Q2 2026, an estimated $6.45K.
AbbVie made up 0.16% of Ballast Inc's portfolio in Q2 2026, its #75 holding.
Ballast Inc first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ballast Inc's 13F filing for Q2 2026, filed 10 Jul 2026.